Decontamination of Geobacillus Stearothermophilus Using the Arca Aerosolized Hydrogen Peroxide Decontamination System

Introduction

The SARS-CoV-2 coronavirus (COVID-19) pandemic has caused a worldwide shortage in personal protective equipment (PPE) including N95 filtering facepiece respirator (FFR) and surgical masks. Both mask types have been shown to dramatically reduce the rate of infection by airborne viruses such as influenza, but the masks are designed for single use before disposal(1). Due to a shortage of FFRs and the critical role FFRs play in protecting health care workers at the outset of the COVID-19 pandemic, the Center for Disease Control recommended limited reuse of decontaminated FFRs to extend supplies of PPE(1)(2). The Occupational Safety and Health Administration has similarly produced guidelines for the limited reuse of FFRs(3).

Aerosolized or vaporized hydrogen peroxide (H₂O₂) is an established reactant for decontaminating surfaces inoculated with resistant bacterial and viral pathogens(4). Recent studies demonstrate that H₂O₂ delivered in an aerosol or vapor as low as 500 ppm has been shown to achieve 1000 times reductions in viral organism activity on inoculated FFRs while maintaining adequate mask fitment through multiple decontamination cycles(5)(6)(7)(8). Previous work has demonstrated that scalable, proof-of-concept H₂O₂ decontamination systems could achieve adequate minimum concentrations reported in the literature to eradicate Coronavirus and other pathogens(9)(10).

To mitigate infection risk with reuse of FFRs, the Food and Drug Administration granted emergency use authorizations (EUAs) to several commercially available hydrogen peroxide FFR decontamination procedures(11). However, the commercially available methods of FFR decontamination are costly and limited in availability(12)(13)(14). The H₂O₂ decontamination methods which received an EUA include those listed in Table 1. The number of maximum decontamination cycles per FFR varies by method with a range of two to 20 cycles(15). The price per institution for these systems can exceed $50,000 (Table 1). Low-resource institutions are often unable to access these services and purchase adequate supplies of PPE(16). Therefore, the development of a smaller-scale, less costly decontamination devices is warranted.

This study seeks to evaluate the efficacy of a low-cost design engineered for use in low-resource settings to expand the supply of decontaminated PPE for safe re-use by frontline workers. Our objectives were to test the device’s efficacy at different H₂O₂ concentrations and Arca device cycle durations by evaluating: 1) the concentration in parts per million (ppm) of H₂O₂ produced inside the chamber and the concentration in ppm of H₂O₂ vented from the chamber, and 2) the decontamination of Mesa Biologic Indicator filter strips (BI) inoculated with 10⁶ Geobacillus Stearothermophilus.

Materials and Methods

The Arca Aerosolized Hydrogen Peroxide Decontamination System (Arca) produces H₂O₂ inside of a sealed stainless steel chamber and circulates the aerosol with four CG IP67 personal computing fans. The Arca uses a Venturi tube design to generate an aerosol: an air compressor forces high velocity air through a tube where the cross-sectional area is reduced with the result of lowering the air pressure (Fig 1). The design lowers the pressure to below 2300 Pa, the vaporization pressure of 10% H₂O₂ in water solution(20). The H₂O₂ is fed to the low pressure opening of the tube, where the low pressure induces partially vaporization, forming small droplets of solution (i.e. an aerosol). A catch is included at the low pressure point to trap large droplets and recirculate them back to the low-pressure area. FFRs are placed on a wire mesh rack inside the chamber and exposed to the H₂O₂ for decontamination (Fig 2).

• Download figure
• Open in new tab

Figure 1.

nebulizer Venturi tube design(21)

• Download figure
• Open in new tab

Figure 2.

Arca interior demonstrating mesh rack, circulating fans, and Venturi tube nozzle

Circulated H₂O₂ aerosol is removed from the chamber interior using a Speedair 4ZL07 condenser unit to avoid operator exposure when removing decontaminated FFRs (Fig 3). The device’s manufacturing and component costs totaled less than $2,000.

• Download figure
• Open in new tab

Figure 3.

Arca exterior showing nebulizer (top), condenser unit (bottom), and electronics housing (left)

The Arca’s decontamination efficacy was evaluated by a testing protocol exposing biologic indicator filter strips (BIs) inoculated with 10⁶ G. Stearothermophilus. We performed a total of 8 trials varying the H2O2 concentration (3% and 12%) and decontamination cycle duration (45, 60, 90, and 120 minutes). Decontamination efficacy was evaluated by H₂O₂ concentration and biologic testing within the device chamber and venting system.

Concentration testing was performed using Bartovartion Very High Level Peroxide Test Strips, which change color to indicate exposure to H₂O₂ at concentrations from 0 to 5000 ppm(22). For each trial, one BI was secured with Scotch Magic™ Tape to an FFR located centrally inside the chamber. An additional concentration strip was placed on the exterior of the door and evaluated for vented H₂O₂ from the chamber after each cycle was completed and the door to the chamber opened. All cycles were performed in a well-ventilated area.

Additionally, one BI was submerged in 3 mL of 3% and one in 3 mL of 12% H₂O₂ for 120 minutes each to serve as negative controls. One BI was not exposed to H₂O₂ to serve as a positive control.

The BIs were handled using sterile technique and after testing were shipped in sealed plastic bags to STERIS labs. The BIs were incubated in 10 mL of Tryptic Soy Broth at 55-60 degrees Celsius for seven days. The cultures were evaluated daily and interpreted as “No growth” only if the medium remained clear without color change or turbidity after seven days(23).

Results

Discussion

The limited supply of FFRs during the SARS-Cov-2 pandemic endangers health care and other frontline workers. While the FDA and CDC have encouraged the decontamination of FFRs for reuse, existing decontamination systems are inaccessible in low-resource settings. Development of systems designed for deployment in low-resource settings will increase the supply of PPE for at-risk personnel.

This study attempted to evaluate a novel device’s ability to eradicate bacterial pathogens from the surface of an FFR without exposing users to unsafe levels of H₂O₂. Our testing demonstrates that the novel Arca device can decontaminate bacterial pathogens without exposing users to high concentrations of H₂O₂. These results are consistent with the literature on existing gaseous H₂O₂ technologies. The eradication of bacteria achieved at every trial suggests that the Arca could achieve adequate decontamination with a lower concentration H₂O₂ solution, a shorter cycle duration, or a smaller volume of H₂O₂. Based on previously reported H₂O₂ testing, the bactericidal properties of the device suggest virucidal efficacy as well,(9)(24).

The Arca’s production cost at less than $2,000 per unit is significantly lower than that of existing commercially available solutions. At scale, this manufacturing cost should decrease. Future iterations of the device could reduce costs further by using more off-the-shelf components in its manufacturing process. The decreased cost of the Arca improves its accessibility in low-resource settings compared with existing FFR decontamination systems.

Conclusion

The Arca Aerosolized Hydrogen Peroxide Decontamination System can safely decontaminate FFRs inoculated with bacteria using a minimum cycle time of 45 minutes with 6 mL of H₂O₂ solution.